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Post-weaning diarrhea (PWD) is an often disease affecting piglets. It is caused mainly by enterotoxigenic 
Escherichia coli (etec) colonization in pig gut. Antibiotics has been used to prevent, combat and control 
pWD and its negative impact on the productivity of pig breeding sector. nonetheless, antibiotics due to 
their wide antibacterial spectrum also can reach beneficial gut bacteria, such as Lactobacillus. Lately, 
essential oils (eos) have emerged as a potential alternative to using antibiotics in animal breeding 
because of their effect on bacterial growth. Commonly, citrus EOs are by-products of food industry and 
the availability of these EOs in the worldwide market is huge. Thus, six commercials citrus EOs were 
evaluated on etec strains, as model of pathogenic bacteria, and on Lactobacillus species, as models of 
beneficial bacteria. In overall, citrus EOs exhibited a selective antibacterial activity with higher effect on 
pathogenic bacteria (ETECs) than beneficial bacteria (Lactobacillus). Brazilian orange terpenes (Bot) 
oil presented the highest selective performance and caused higher disturbances on the normal growth 
kinetic of etec than on Lactobacillus rhamnosus. The action was dose-dependent on the maximal 
culture density (A) and the lag phase duration (λ) of the etec. the highest sub-inhibitory concentration 
(0.925 mg/mL) extended the λ duration to ETEC eight times (14.6 h) and reduced A in 55.9%. For L. 
rhamnosus, the λ duration was only extended 1.6 times. Despite the fact that limonene was detected 
as the major compound, the selective antibacterial activity of the citrus EOs could not be exclusively 
attributed to limonene since the presence of minor compounds could be implicated in conferring this 
feature.
The incidence of post-weaning diarrhea (PWD) is a serious problem in the worldwide pig industry, causing severe 
economic losses due to increased pig morbidity and mortality, decreased animal growth rate and increased need 
for medication to treat animals1,2. PWD is caused mainly by enterotoxigenic Escherichia coli (ETEC) that is highly 
present in the gastrointestinal tract of affected pigs. This pathotype is characterized by production of adhesins, 
which intermediate bacterial adherence to the intestine1,3, and toxins that lead to hypersecretion of water and 
electrolytes4,5. The presence of ETEC in the environment is an important transmission factor since they can sur-
vive protected in the manure for about 6 months. Furthermore, E. coli multiply rapidly and can reach up to 109 
CFU per gram of feces, with the infection produced dependent on the degree of bacterial colonization6.
To control PWD outbreaks caused by enterobacteria as ETECs, antibiotics have frequently been included in 
the diet of weaned piglets as treatment, preventive measure, or growth promoter. However, continuous antibiotic 
use has been suggested as one cause of the emergence and worldwide dissemination of resistant bacteria. For 
example, currently, there is great concern about the emergence of plasmid-mediated colistin resistance (mcr-1) 
in E. coli, a resistance mechanism to an important antibiotic class in human health, polymyxins, which was 
largely used in pig production as growth promoter7–9, but banned its use for this purpose by the European Union 
legislation10 since 2006, and recently, by China11, Japan12 and Brazil legislations13. However, therapeutic use of 
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colistin is still allowed following the current recommendation of the European Medicine Agency, which restrict 
the rational use of colistin to treat clinical cases in livestock animals14. Moreover, the wide spectrum activity of 
some antibiotics can affect gut microbiota since they can kill or inhibit both pathogenic and beneficial bacteria. 
Thus, longtime antibiotic use can provoke decreased microbiota diversity and increased chances of pathogens 
colonizing the gut2. On the other hand, it is well known that Lactobacillus is the major group of beneficial bacteria 
presented in pig gut microbiota, which has been identified as an important group of bacteria able to prevent gut 
diseases15. Possible Lactobacillus mechanisms to fight post-weaning infections in piglets have been described 
as (i) the direct inhibition of pathogen growth and its virulence by secretion of antimicrobial metabolites as 
bacteriocins, (ii) the modulation of microbiota composition and its activity and, (iii) the stimulation of the host 
immune system and improvement of intestinal barrier integrity2. In this scenario, finding an antimicrobial feed 
additive with a selective antibacterial activity, high spectrum activity on pathogenic bacteria and a reduced or not 
effect on beneficial bacteria like Lactobacillus would be very desirable. In the last decade, phytogenic compounds 
like essential oils (EOs) have received more attention as potential alternatives to replace antimicrobial growth 
promoters (AGP) in animal production due to their known biological properties: antimicrobial, antioxidant and 
anti-inflammatory16,17. A few studies have reported that some EOs can suppress pathogenic bacteria while stim-
ulating beneficial microorganisms such as Lactobacillus in the pig gut18,19. Specifically, the citrus EOs, which are 
by-products of orange juice production20, could be an excellent alternative for that purpose since they have shown 
good potential to fight pathogenic bacteria such as Listeria spp.21, Salmonella spp.22, E. coli, Staphylococcus aureus 
and Bacillus cereus23. Furthermore, the use of citrus EOs in animal feed could become feasible since there is a huge 
availability of these oils in the worldwide market. Therefore, the aim of this study was to evaluate the selective 
antibacterial activity of six commercial citrus EOs on ETEC strains isolated from pig gut and on two Lactobacillus 
species belonging to ATCC, as well as to determine the chemical composition of these citrus EOs.
Results
Antibacterial activity. Screening by disc diffusion. The antibacterial activity screening of the six citrus EOs 
on the ETECs and Lactobacillus species is shown in Table 1. The association of inhibition zone diameter (IZD) 
means of six citrus EOs, when evaluated on ETECs and Lactobacillus species, by principal component analysis 
(PCA), showed that the first principal component explained 96.62%, and the second component 2.80% of the 
total variance (Fig. 1). Therefore, a good representation of antibacterial activity of these citrus oils was obtained. 
The IZD data showed that all the citrus oils had high antibacterial activity on all the ETECs, while low activity 
on the two Lactobacillus species was observed (Table 1). Consequently, it is possible to highlight these citrus oils 
as having a selective antibacterial activity. Furthermore, in contrast to the antibiotic colistin, an antibiotic that 
presented a selective performance (antibacterial activity on ETECs and no activity on Lactobacillus species), 
the citrus EOs showed superior performance on ETECs. Looking at the PCA (Fig. 1), four of the six citrus EOs, 
BOT, OOPE, CT and OPO, were the most selective oils since a closer association of their antibacterial activity 
with ETECs than with Lactobacillus species was observed. IZDs of these oils on ETECs were >18 mm. However, 
from these four citrus EOs, BOT stood out by exhibiting the best selective antibacterial activity (p < 0.05), since it 
presented the largest IZDs to all ETECs and considerable low IZDs (p < 0.05) to the two evaluated Lactobacillus 
species. Therefore, this oil was selected to continue the study.
Regarding the susceptibility of ETECs, E. coli U7 was the most sensitive strain (p < 0.05) to the activity of 
the citrus EOs, since the largest IZDs were observed for this ETEC. Conversely, E. coli U21 was the least sensi-
tive or the most resistant ETEC, since were gotten the lowest IZDs (p < 0.05) on this bacterium. In the case of 
Lactobacillus species, it was observed that L. plantarum was the more resistant beneficial bacterium to the citrus 
EOs activity, since lowest IZDs were gotten on this bacterium. This behavior of the sensitivity for the bacteria 
tested is also represented in the PCA (Fig. 1), where the farthest association of E. coli U21 to the EOs is observed, 
and the closer association of L. rhamnosus than of L. plantarum to EOs can be observed. Therefore, E. coli U21 
Strain E. coli U7 E. coli U21 E. coli U23 E. coli U25 L. rhamnosus ATCC 7469 L. plantarum ATCC 8014
Essential 
oil*** IZD** PC** % I IZD** PC** % I IZD** PC** % I IZD** PC** % I IZD** PC** % I IZD** PC** % I
1 BOT 27.4 ± 0.8ab,A 17.4 ± 0.2 157.4 20.1 ± 0.3a,C 12.4 ± 0.3 161.6 22.8 ± 0.9a,B 13.3 ± 0.2 171.0 25.4 ± 1.5a,AB 15.6 ± 0.7 162.4 9.9 ± 0.3bc,A 6.0 ± 0.0 165.7 8.8 ± 0.4ab,B 6.0 ± 0.0 161.6
2 TLOP 24.3 ± 1.1bc,A 15.3 ± 1.8 158.7 12.5 ± 1.7c,B 12.4 ± 0.4 100.8 14.9 ± 0.8b,B 12.9 ± 0.1 115.6 22.3 ± 2.5a,A 16.7 ± 1.2 133.9 8.5 ± 0.2d,A 6.0 ± 0.0 141.3 8.0 ± 0.3b,A 6.0 ± 0.0 133.9
3 OPO 23.8 ± 1.4c,A 16.1 ± 1.8 148.2 18.1 ± 0.2b,B 12.5 ± 0.5 144.6 20.8 ± 1.6a,AB 12.8 ± 0.4 162.9 22.2 ± 1.6a,AB 16.4 ± 0.3 135.6 9.1 ± 0.3 cd,A 6.0 ± 0.0 151.8 8.4 ± 0.4ab,B 6.0 ± 0.0 140.2
4 OPOFF 13.4 ± 0.9d,A 17.1 ± 0.5 78.3 9.3 ± 0.9d,B 12.7 ± 0.1 73.2 10.1 ± 0.4c,B 12.6 ± 0.1 80.2 13.3 ± 0.9b,A 15.6 ± 1.2 85.4 6.0 ± 0.0e,A 6.0 ± 0.0 100.0 6.0 ± 0.0c,A 6.0 ± 0.0 100.0
5 OOPE 25.7 ± 0.6abc,A 16.9 ± 0.6 151.1 19.2 ± 0.5ab,B 12.6 ± 0.5 152.4 22.3 ± 1.5a,AB 13.0 ± 0.5 172.7 22.9 ± 1.3a,A 15.8 ± 0.4 144.7 10.4 ± 0.5ab,A 6.0 ± 0.0 173.2 8.8 ± 0.1ab,B 6.0 ± 0.0 146.8
6 CT 28.6 ± 2.2a,A 17.7 ± 1.1 161.9 19.8 ± 0.8ab,B 12.1 ± 0.6 163.0 22.1 ± 1.2a,B 12.8 ± 0.7 172.4 22.5 ± 0.7a,B 15.8 ± 0.5 142.0 10.9 ± 0.5a,A 6.0 ± 0.0 182.4 9.1 ± 0.4a,A 6.0 ± 0.0 151.0
Table 1. Antibacterial activity of the citrus essential oils on ETECs strains isolated from pig gut and 
Lactobacillus strains*. ***OOPE = Orange oil phase essence, OPO = Orange peel oil, BOT = Brazilian orange 
terpenes, TLOP = Tahiti lime oil phase, OPOFF = Orange peel oil five fold and CT = Citrus terpenes. **IZD: 
Inhibition zone diameter; PC: Positive control (Colistin); %I: inhibition of essential oil in relation to colistin. 
*Values are means ± Standard Deviation (SD) of triplicate determinations expressed in mm including 6 mm 
of paper disk. a,bMean values within a column having different superscripts are significantly different (essential 
oils) by the least significant difference Tukey test (p < 0.05). A,BMean values within a row having different 
superscripts are significantly different (strains) by the least significant difference Tukey test (p < 0.05).
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was selected as the most resistant ETEC and L. rhamnosus selected as the most sensitive beneficial bacterium to 
the antibacterial activity of the citrus oils.
Determination of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC). The 
MIC and MBC determinations were made only using the most selective EO, which was BOT, the most resistant 
E. coli strain (E. coli U21), and most sensitive Lactobacillus species (L. rhamnosus), as determined in the screen-
ing phase. The MIC and MBC values for BOT, as determined by survival curves and resazurin test, are shown in 
Table 2. The MIC for E. coli U21 was 1.85 mg/mL (Fig. 2a), which was also the MBC for this bacterium. The MIC 
for L. rhamnosus was 3.70 mg/mL (Fig. 2b) and the MBC was 7.40 mg/mL (Table 2). Thus, these results reaffirm 
the selective antibacterial activity of this citrus oil, since to totally inhibit the growth of the beneficial bacterium 
L. rhamnosus required an EO concentration equivalent to twice the MIC observed for E. coli U21, and to kill it 
necessitated a concentration of four times the E. coli U21 MIC. Therefore, pathogenic bacterium was more sensi-
tive to BOT than beneficial bacterium.
Bacterial growth modeling and calculation of kinetic parameters. The curves representing the bacterial growth 
kinetic for E. coli U21 and L. rhamnosus, when they were exposed to different concentrations of the BOT, are 
shown in Fig. 2. The Gompertz model modified by Zwietering et al.24 was used to fit the data of the bacterial 
growth (Eq. 6). The parameters obtained of this model for both bacteria are shown in Table 3.
The survival curves or growth kinetics of E. coli U21 (Fig. 2a) showed that the four highest EO concentra-
tions totally inhibited the growth of this bacterium and the growth was only observed for concentrations equal 
to or under 0.925 mg/mL of BOT oil. In the case of L. rhamnosus (Fig. 2b), bacterial growth was observed up to 
the concentration of 1.85 mg/mL of BOT and the three highest concentrations caused complete inhibition of 
this bacteria. Furthermore, we observed that EO concentration was able to provoke higher disturbances on the 
normal growth kinetic of E. coli U21 than L. rhamnosus. The modified Gompertz model allowed us to evaluate 
these disturbances with more accuracy through the three main biological parameters that it considers: maximal 
bacterial culture density (A), maximum specific growth rate (µmax) and lag phase duration or adaptation time (λ).
The values of parameter A were significantly affected (p < 0.05) for E. coli U21, since A was greatly reduced as 
the EO concentration was increased (Table 3). For instance, A was reduced in 38.9% at the lowest concentration 
and in 55.9% at the highest subinhibitory concentration (0.925 mg/mL), in contrast with the control (0 mg/mL 
of BOT). The parameter A had an inverse sigmoidal behavior as function of the EO concentration (Fig. 3a) and 
the mathematical function that describes this behavior to E. coli U21 is shown in Eq. (1), which had a good fit 
(R2 = 0.91). Regarding L. rhamnosus, this parameter was not affected by EO concentrations (Table 3), no signif-
icant differences were detected (p < 0.05), and it was considered the average in the general model of this bacte-
































Figure 1. Principal component analysis (PCA) of six citrus EOs based on their antibacterial activity on ETECs 
strain and Lactobacillus species. OOPE = Orange oil phase essence, OPO = Orange peel oil, BOT = Brazilian 
orange terpenes, TLOP = Tahiti lime oil phase, OPOFF = Orange peel oil five fold and CT = Citrus terpenes.
Bacterial strain
Brazilian Orange Terpens
MIC (mg/mL)a MBC (mg/mL)
E. coli U21 1.85 1.85
L. rhamnosus ATCC 7469 3.70 7.40
Table 2. MIC and MBC for Brazilian orange terpenes (BOT). aDetermined by survival curves and resazurin test.









































































Figure 2. Bacterial growth kinetic as function of BOT concentrations of E. coli U21 (a) and L. rhamnosus 
(b). The dots are the experimental values; the vertical bars are the standard deviation and the curves are the 
modified Gompertz model (Eq. (6)). BOT = Brazilian orange terpenes
CEOc
(mg/mL)
E. coli U21 L. rhamnosus ATCC 7469
A (OD600 nm)a µmax (h−1)b λ (h)a R2 A (OD600 nm)b µmax (h−1)b λ (h)a R2
14.80 — — — — — — — —
7.40 — — — — — — — —
3.70 — — — — — — — —
1.85 — — — — 1.143 ± 0.027 0.165 ± 0.005 26.61 ± 2.19 0.99
0.925 0.289 ± 0.016 0.078 ± 0.004 16.88 ± 0.97 0.99 1.192 ± 0.047 0.215 ± 0.104 23.85 ± 3.95 0.99
0.463 0.400 ± 0.054 0.058 ± 0.018 8.16 ± 1.31 0.99 1.210 ± 0.040 0.197 ± 0.089 20.24 ± 3.37 0.99
0.231 0.437 ± 0.060 0.072 ± 0.008 3.04 ± 0.57 0.98 1.216 ± 0.032 0.202 ± 0.048 19.55 ± 2.34 0.99
0.116 0.400 ± 0.053 0.097 ± 0.006 2.58 ± 0.45 0.98 1.210 ± 0.028 0.204 ± 0.035 19.35 ± 1.77 0.99
0.00 0.655 ± 0.049 0.073 ± 0.012 2.30 ± 0.55 0.99 1.176 ± 0.054 0.148 ± 0.008 16.61 ± 1.94 0.99
Table 3. Calculated parameters* of Modified Gomperzt Model (Eq. (6)24) for each evaluated concentration of 
Brazilian orange terpenes (BOT). *A = maximal bacterial culture density (OD600 nm), µmax = the maximum 
specific growth rate (h−1), λ = the lag phase duration (h). (−)Undetermined parameters due to total inhibition. 
cConcentration of essential oil. aThere are significant differences in the growth kinetics parameters after 
exposure to essential oil concentrations (p < 0.05). bNo significant differences were observed (p < 0.05).
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The maximal growth rate, that is, the parameter µmax for both bacteria, E. coli U21 and L. rhamnosus, was not 
affected by the EO concentrations since no significant differences were detected among the concentrations tested 
(p < 0.05). Consequently, it was considered an average growth rate of each bacterium for the general model, 
0.076 ± 0.014 h−1 to E. coli U21 and 0.189 ± 0.026 h−1 to L. rhamnosus. As observed, the growth rate was quite 
higher for L. rhamnosus than E. coli U21.
Regarding parameter λ, which is the lag phase duration, we observed that for both bacteria this parameter 
increased as the EO concentration was increased. For E. coli U21, λ was slightly longer than control at the three 
lowest EO concentrations, but from 0.463 mg/mL to above, the lag phase was notably increased. For instance, λ 
increased approximately eight times at the highest subinhibitory concentration of BOT oil (0.925 mg/mL), in 
contrast with the control (0.00 mg/mL). Therefore, this parameter had an exponential behavior as function of the 
EO concentration (Fig. 3b) and the mathematical function that describes it is shown in Eq. (2), which had a good 
fit (R2 = 0.97). For L. rhamnosus, λ only suffered a significant increase, approximately 1.6 times at the highest 
effective subinhibitory BOT concentration (1.85 mg/mL). The behavior of λ to this beneficial bacterium was lineal 
as function of the EO concentration (Fig. 4); the mathematical function that describes it is shown in Eq. (3) and 
it had a good fitting (R2 = 0.93).
λ = . .e2 52 (2)EC
C2 06( )EO
λ = . + .C4 971 18 06 (3)LR EO
Finally, the modified Gompertz model to describe the bacterial growth kinetics as function of EO concentra-
tion (0.00 < CEO < 14.80 mg/mL) and time of exposure (in hours), is shown in Eq. (4) for E. coli U21, and in Eq. 
(5) for L. rhamnosus. Additionally, the model for E. coli U21 was plotted in 3D and is shown in Fig. 3c. The surface 
obtained highlights the shifts in the bacterial growth kinetic of E. coli U21 as function of initial EO concentration.
Figure 3. Parameters A (a) and λ (b) of the modified Gompertz model (Eq. (6)) to E. coli U21 as function 
of the BOT concentration. The dots are the experimental values; the vertical bars are the standard deviation 
and the curves are the model of Eqs. (1) and (2), respectively. (c) General model that describes the bacterial 
culture density of E. coli U21 as function of the time of treatment and the BOT concentration applied (Eq. (4)). 
BOT = Brazilian orange terpenes.
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Therefore, evaluation of growth bacterial kinetic parameters confirmed that the citrus oil, BOT, had a stronger 
effect on the pathogenic bacterium than on the beneficial bacterium, provoking higher disturbances in its growth 
kinetics. This proves the selective antibacterial features of the BOT oil.
chemical composition characterization of essential oils. The chemical composition of the six citrus 
EOs is shown in Table S1 (Supplementary information). Overall, the identification of the chemical composition of 
each citrus EO by both columns was quite similar, as is observed in the individual factor map of the MFA (Fig. 5a), 
the polar and non-polar identification points were very close to each other. In addition, a good representation of 
the chemical composition data was obtained, since the first dimension of the MFA explained 53.89% and the sec-
ond dimension explained 33.84% of the total variance. For the six citrus oils, limonene was detected as the major 
compound; however, TLOP had a negative association with this compound in both dimensions (Fig. 5b), since it 
presented the lowest relative amount of limonene (46.53%/47.46%).
Moreover, it was observed that BOT, CT, OOPE and OPO had a positive association with limonene in the two 
dimensions of the MFA and OPOFF had that positive association in the second dimension, showing all these EOs 
presented higher amount of limonene (Fig. 5b). However, OPOFF presented a fully different chemical profile than 
BOT, CT, OOPE and OPO oils (Fig. 5a) and it was the oil that presented the weakest antibacterial activity. BOT, 
CT, OOPE and OPO oils presented a very close chemical composition profile and they were characterized by hav-
ing the highest selective antibacterial activity. Therefore, this allows us to suggest that the antibacterial activity of 
the citrus EOs could not be attributed specifically to limonene. Minor common compounds such as cis-limonene 
oxide, trans-carveol, carvone, trans-limonene oxide, cis-p-Mentha-2,8-dien-1-ol, trans-p-Mentha-2,8-dien-1-ol, 
perrilla alcohol, cis-carveol, cis-p-Mentha-1(7),8-dien-2-ol and 1,8-menthadien-4-ol (Fig. 5b) were detected in 
these four citrus EOs and they were either present exclusively in these four EOs or in higher amounts than TLOP 
and OPOFF oils. Therefore, these minor compounds could be implicated to confer the selective and highest anti-
bacterial activity of BOT, CT, OOPE and OPO oils.
In addition. we observed that TLOP and OPOFF had a different chemical profile. The TLOP profile is shown 
in the third quadrant of the MFA (Fig. 5b); besides limonene, this oil had a high amount of p-cymene and 
γ-terpinene. The OPOFF profile is shown in the second quadrant of the MFA (Fig. 5b), and linalool was detected 
as second major compound in it.
Discussion
Citrus EOs are one of the main by-products of the orange juice industry and could have several applications 
besides cosmetology and the food industry. Citrus oils have been reported as having antimicrobial proper-
ties20–22,25, but testing their antimicrobial activity on bacteria affecting animal farms has not been greatly men-
tioned. E. coli causing post-weaning diarrhea in piglets during their early life is a critical problem for the pig 
industry2. The antibacterial activity of commercial citrus EOs evaluated in this study on E. coli strains isolated 
from pig gut and on Lactobacillus bacteria showed that, in overall, citrus EOs presented a selective antibacte-
rial activity, having higher activity on pathogenic bacteria E. coli than on beneficial bacteria Lactobacillus spp. 
Figure 4. Parameters λ of the modified Gompertz model (Eq. (6)) to L. rhamnosus as function of the BOT 
concentration. The dots are the experimental values; the vertical bars are the standard deviation and the curves 
are the model of Eq. (3). BOT = Brazilian orange terpenes.
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The selectivity towards bacterial pathogens by EOs or EO compounds rather than beneficial bacteria have been 
already reported18,26,27, EOs or single EO compounds were shown to have higher inhibitory effect on E. coli 
O157:H7, E. coli K88, S. typhimurium than on Lactobacillus and Bifidobacterium spp18. As an alternative to AGPs, 
the selectivity of citrus oils could be an important feature of antimicrobial spectrum, which commonly has not 
been considered to conventional AGPs long used, since the aim is to have an effect on the pig gut. Thus, current 
search for antimicrobial substances as alternatives to AGPs should consider selectivity aspects between patho-
genic and beneficial gut bacteria. The lower effect on beneficial bacteria by an AGP and its potential alternatives 
(such as citrus EOs) would be desirable since beneficial bacteria such as Lactobacillus spp. contribute to fighting 
pathogen colonization in the gut and preventing gut infections. Thereby, reinforcing gut microbiota and contrib-
ute to improve animal health27.
The capability of citrus EOs to inhibit pathogenic bacteria has been well reported in several studies. For 
instance, tangerine EO (Citrus reticulata) was reported as having an inhibitory effect on S. aureus, Bacillus sub-
tilis, and Pseudomonas aeruginosa28. Another study proved the high effectiveness of the lemon EO (Citrus limon 
Figure 5. Multiple factor analysis (MFA) of the chemical composition profile of six citrus commercial EOs. 
The individual factor map of the overall chemical composition profiles by polar and non-polar identification (a) 
and biplot of the detailed chemical composition profile (b). OOPE = Orange oil phase essence, OPO = Orange 
peel oil, BOT = Brazilian orange terpenes, TLOP = Tahiti lime oil phase, OPOFF = Orange peel oil five fold and 
CT = Citrus terpenes.
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L. Burm) to inhibit several strains of Listeria monocytogenes, S aureus and Salmonella enterica associated with 
foodborne diseases25 Also, it has been reaffirmed the anti-salmonella22 and anti-listeria21 activities of several com-
mercial citrus oils. Specifically, the antibacterial activity of citrus oils on E. coli has been investigated. Tangerine 
EO (Citrus reticulata) was shown to be effective to produce an inhibition of 14.6 ± 1.1 mm on E. coli28. A total 
inhibition of E. coli growth by this oil was found at 1.96 mg/mL29. A close value to this MIC was found for BOT oil 
in our study (1.85 mg/mL = 0.21%v/v). Other citrus EOs such as bergamot, orange and lemon were also effective 
to produce inhibitions ≥18 mm on E. coli O157, but full inhibition of the growth of this bacterium was reported 
at higher MICs than the BOT oil, between 0.5–1.0%v/v30. Similarly, another study reported higher MICs than the 
BOT to mandarin and lemon EOs on E. coli, 5 and 30 µL/mL, respectively31. In addition, the EO of sweet orange 
(Citrus sinensis Osbeck) has presented an inhibitory effect on E. coli at 18.8 µL/mL32, also considered as a high 
MIC in contrast to the BOT oil. Conversely, the non-effectiveness of several citrus oils to fight E. coli affecting 
animals, such as E. coli associated with poultry colibacillosis, has been reported33. In comparison, the citrus EOs 
tested in our study were quite effective in treating E. coli affecting pigs.
Furthermore, some studies highlighted that citrus EOs have higher effectiveness to inhibit Gram-positive 
pathogenic bacteria than Gram-negative pathogenic bacteria30,34. However, in our study, the opposite was 
observed, since the Gram-negative E. coli was more sensitive than the Gram-positive Lactobacillus spp. to the 
activity of the citrus oils. The difference in the sensitivity to EOs between these two groups of bacteria has been 
hypothesized to be the consequence of differences in the cell wall structure, since Gram-positive bacteria lack an 
outer membrane (OM), which Gram-negative bacteria have. This OM contains lipopolysaccharides (LPS) with 
polar ends (O-polysaccharides) and transmembrane channels (porins), which permit the passage of hydrophilic 
solutes and make difficult for hydrophobic compounds to diffuse such as EOs components into the cell. Therefore, 
this would allow Gram-negative bacteria be more resistant to EOs35. Nonetheless, the antibacterial spectrum of 
EOs depends on the specificity of the functional groups of EO compounds to single or multiple targets. Some EO 
compounds have the ability to disintegrate the OM of Gram-negatives as E. coli, release the material associated to 
this membrane and penetrate the cell, provoking a disruptive effect36. Probably, the compounds present in citrus 
EOs may have this ability due to their higher effectiveness observed on this Gram-negative bacterium, E. coli. 
On the other hand, the antibacterial activity of citrus oils on Gram-positive beneficial bacteria has been little 
reported. Orange, lemon, mandarin and grapefruit EOs had a low inhibitory effect on Lactobacillus sakei and 
Lactobacillus curvatus, exhibiting the orange oil the lowest effect on these bacteria (12.8 ± 0.5 and 13.5 ± 0.2 mm, 
respectively)37. The authors demonstrated that the inhibitory effect of these four oils was dose-dependent causing 
inhibition of those Lactobacillus species only at the highest concentrations tested37. This was also noticed in our 
study, where the citrus oils exhibited IZDs lower than 11 mm to Lactobacillus species. Moreover, L. rhamno-
sus was inhibited at a high BOT concentration and killed even at an upper concentration, thus showing  BOT 
had a low antibacterial activity on L. rhamnosus. Although general structures and biosynthesis pathways among 
Gram-positive bacteria are conserved, some Gram-positive bacteria, such as Lactobacillus spp., could show 
low sensitivity to antimicrobials, such as EOs, since the cell wall of Gram-positive lactic acid bacteria (LAB) as 
Lactobacillus spp. possess unique properties that could confer intrinsic resistance to some antimicrobial agents38. 
For instance, the intrinsic resistance to antibiotics of some Lactobacillus (e.g. to vancomycin) would be related to 
the fact of having a D-lactate instead of D-alanine as the last amino acid in the peptidic chain of the peptidoglycan 
layer of their cell wall38,39, which would avoid the antibiotic binds to the peptidic chain and cause the inhibition 
of these bacteria40.
Additionally, it was observed that BOT oil caused higher disturbances on the growth kinetics of E. coli than L. 
rhamnosus, significantly affecting its maximal culture density and the lag phase duration. Both parameters were 
dose-affected and changed as function of the BOT concentration. The higher dose-dependent effect of some EOs 
and single EO compounds on the growth kinetic of E. coli than on Lactobacillus spp. has already been observed27. 
Oregano, thyme and rosemary EOs, carvacrol, eugenol and thymol provoked higher reduction on the maximal 
culture density of E. coli strains than Lactobacillus fermentum and Lactobacillus reuteri with increasing of the con-
centration of EOs/EO compounds27. Also, the dose-dependent effect of carvacrol to extend the lag phase of E. coli 
by increasing the concentration of this compound has been proved41. In addition, some combinations of EOs have 
been reported as more efficient to cause an increase of the E. coli lag phase. For instance, combinations of oregano 
with basil EOs and oregano with lemon balm EOs were able to significantly increase the E. coli lag phase, approxi-
mately 7.4 h and 3.6 h longer, respectively, compared to when oregano EO was used alone42. Regarding L. rhamno-
sus, in our study, we observed only the lag phase duration was extended as the BOT concentration was increased. 
This effect on L. rhamnosus has been previously observed with the oil of Melaleuca armillaris, which additionally 
reduced the growth rate and final culture density with increasing of the EO concentration43. Therefore, this oil 
had a higher dose-dependent effect on the growth kinetic parameters of L. rhamnosus than the citrus oil (BOT) 
tested in our study. Moreover, a recent study observed that Eucalyptus globulus and Pimenta pseudocaryophyllus 
EOs presented a dose-dependent effect on the lag phase of L. rhamnosus as well; however, P. pseudocaryophyllus 
oil caused higher extension of this parameter in comparison to E. globulus oil at the same sub-MICs44.
Limonene has been shown as a major compound of citrus EO composition and most of their biological activ-
ities have been attributed to this compound. All citrus oils evaluated in our study presented limonene as the 
major compound. However, the mismatching between limonene content and antibacterial activity of these oils 
suggested that their antibacterial activity cannot be attributed exclusively to limonene. Some studies have already 
reported the lack of antibacterial activity of limonene individually tested. For instance, the pompia EO (Citrus 
limon var. pompia), which presented limonene as major compound (28%), at a concentration of 256.3 mg/mL, 
presented an antibacterial effect on several pathogenic bacteria, but when limonene was evaluated alone, it did 
not exhibit any antibacterial effect45. Thus, this proved that limonene would not be the compound responsible for 
the antibacterial activity observed for this oil. Nonetheless, coexisting minor compounds in citrus oils could con-
tribute to conferring the antibacterial property of these oils. In mandarin EO, compounds like octanal, decanal, 
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citral, citronellal, linalool, α-sinensal and thymol were suggested as possible collaborators to the antibacterial 
activity, when this oil (with 56.8% of limonene) was tested against Gram-negative and Gram-positive bacte-
ria28. Other minor compounds, belonging to oxygenated monoterpenes class, such as 4-terpineol, α-terpineol, 
cis-geraniol, β-citral, nerol and α-citral, might also be implicated in conferring the antibacterial activity of citrus 
oils, since they have been detected in high amounts in the composition of the citrus EO that presented high anti-
bacterial activity25. Minor oxygenated monoterpenes compounds (cis-limonene oxide, trans-carveol, carvone, 
trans-limonene oxide and perrilla alcohol) were also detected in the group of the most selective citrus oils of our 
study. Possibly, these compounds might play an important role in conferring the selective antibacterial activity 
of citrus EOs. In addition, an orange cold pressed EO rich in limonene (85.3%) presented an antibacterial activ-
ity on E. coli ten times higher than limonene alone, and even minor compounds, such as linalool, pinene and 
terpineol, presented a higher activity than limonene46. Furthermore, the antibacterial activity of limonene has 
been shown to be variable and depending on its stereoisomeric form present in the EO. The (−) stereoisomer 
of limonene could inhibit E. coli at a lower concentration (8 mg/mL) than the (+) stereoisomer (11 mg/mL). On 
the other hand, limonene alone has been proved to stimulate the growth of beneficial bacteria as L. fermentum, 
instead of having any inhibitory effect on it27. Likewise, limonene has been reported as not effective to inhibit 
several Lactobacillus species including L. rhamnosus ATCC 746945, the bacteria also evaluated in our study, and 
which showed be the more resistant to the antibacterial activity of the citrus oils proved. Therefore, it would 
be possible to infer that limonene could collaborate with the selective activity of citrus oils when it is present 
in the gut, promoting the beneficial bacteria while other minor compounds could act in inhibiting pathogenic 
bacteria. It has been reported that in an EO, major and minor components probably act in synergism to confer 
the biological properties of the EO47. When an EO compound is proved, individually, its effect may differ from 
the effect that this compound may have in combination with the other compounds inside the EO. Thus, it would 
be recommended the use of the whole EO instead of single EO compounds, since every compound inside an 
EO could exert a different mechanism of action on the bacteria cell48, and this could reduce the chance to bac-
teria develop easily resistance to the EO. Contrariwise, bacteria could develop a rapid and easy mechanism of 
resistance to a single EO compound, as in the case of an antibiotic, which consist of a single compound. Several 
mechanisms of action of EOs have been proposed in the literature. The mechanism of action comprises a serie of 
events on the bacterial cells. Initially, they can destabilize the cellular architecture, leading to the breakdown of 
membrane integrity and thus increased permeability of cellular constituents. This disrupts many cellular activi-
ties, including energy production, membrane transport, and other metabolic regulatory functions48. In addition, 
EOs can alter the membrane fatty acids composition, the membrane proton motive force and affect proteins in 
the cytoplasmatic membrane. Additionally, EOs can interfere with the quorum sensing activity, decreasing the 
proteolytic activity, biofilm formation, and virulence factors expression and their functions, as well as to affect the 
metabolome of bacteria35.
In conclusion, our study highlights as an important feature of antimicrobial spectrum the selectivity between 
pathogenic and beneficial gut bacteria, which should be considered when searching for antimicrobial substances 
as alternatives to conventional AGPs, since the aim is to have an effect on the pig gut. Our study has proved, 
by a screening, MIC determination, and growth kinetic parameters evaluation, the selective antibacterial activ-
ity of citrus EOs on E. coli and Lactobacillus spp., thus suggesting these EOs as potential alternatives to AGPs. 
Consequently, based on the selective performance and the huge viability in the global market of citrus EOs, the 
possible application of these oils in the pig production sector could turn feasible. In addition, chemical compo-
sition characterization showed that minor compounds present in these citrus oils would be implicated in con-
ferring their selective activity, instead of limonene, the major present compound, playing this role exclusively. 
Finally, our results motivate further research to clarify, for instance, the possible mechanism of action that citrus 
oils would have on pathogenic and beneficial bacteria as well as their direct effect on the pig gut and on the micro-
biota resident in it.
Material and Methods
essential oils supply. Six citrus commercial EOs were used in the study. These were by-products from 
orange juice production and were supplied by a factory from São Paulo State, Brazil. The oils were named by the 
factory as follows: Orange oil phase essence (OOPE), Orange peel oil (OPO), Brazilian orange terpenes (BOT), 
Tahiti lime oil phase (TLOP), Orange peel oil five fold (OPOFF) and Citrus terpenes (CT). Once the samples were 
received, they were kept in amber bottles under refrigeration (4 °C) until use.
Bacterial strains. The evaluated bacterial strains in this research were four ETECs strains and two 
Lactobacillus species. The ETECs strains were isolated from pig gut and provided by The Swine Heath Laboratory 
of the Department of Preventive Veterinary Medicine and Animal Health from FMVZ-São Paulo University: E. 
coli U7 (K88+/LT+/STb+), E. coli U21 (K88+/LT+/STb+/F18+/Sta+), E. coli U23 (LT+/STb+/F18+) and 
E. coli U25 (LT+/STb+/F18+/Sta+). The two Lactobacillus species were standard cultures from the American 
Type Culture Collection (ATCC), L. plantarum ATCC 8014 and L. rhamnosus ATCC 7469. ETECs strains were 
cultivated in Tryptic Soy Agar-Difco (TSA, DifcoTM) at 37 °C for 18–20 h and Lactobacillus species in MRS (Man, 
Rogosa and Sharpe agar, DifcoTM) agar at 30 °C for 48 h. After activation, the bacteria were sub-cultured in 
Brain-Heart Infusion broth or MRS both (DifcoTM) supplemented with 15% of glycerol. After incubation, they 
were stored at −20 °C until their use.
Antibacterial activity. Screening by disc diffusion. All EOs were initially screened by disc diffusion 
method, following the standard protocol M02-A11 from the Clinical and Laboratory Standards Institute49. EO 
solutions were prepared at 90% (v/v), using acetone as an emulsifier to improve dispersion. ETECs strains (E. coli 
U7, U21, U23 and U25) were grown on TSA agar and Lactobacillus species on MRS agar. Isolated colonies of each 
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bacterium were transferred to tubes containing sterile saline solution (0.85%) until reaching an optical density 
within 0.08 to 0.1 abs, at 625 nm, which corresponds to 0.5 McFarland standard, therefore containing ~1–2 × 108 
CFU/mL49. After this, Mueller Hinton (MH) agar plates (E. coli) and MRS agar plates (Lactobacillus spp.) were 
inoculated and the bacterial inoculum spread. Seven microliters of each EO solution (90% v/v) were placed on 
6-mm diameter sterile paper discs (Whatman N° 3), which was transferred to the inoculated agar plates. Three 
discs with the same EO solution were placed in each plate; one disc of colistin (15 µg/disc) was used as a positive 
control, and one disc of acetone (10 µL/disc) was used as a negative control since its non-antimicrobial activity 
was proved. Then, the agar plates were incubated at 37 °C for 24 h (E. coli) and at 30 °C for 48 h (Lactobacillus 
spp.). Inhibition zone diameters (IZD) were measured after incubation with the aid of a caliper rule. The experi-
ment was carried out in three independent replicates.
The EO presenting the highest IZDs for the four ETECs strains and the lowest IZDs for the two Lactobacillus 
species was considered as the best selective EO between pathogenic and beneficial bacteria and was thus selected 
for further investigation. Referring to the bacterial strains, the most resistant ETEC strain and the most sensitive 
Lactobacillus specie to the activity of EOs were selected to continue with the study.
Determination of minimal inhibitory concentration (MIC). The determination of the MIC of the selected EO 
was performed by microdilution assay in a 96-well microplate following the standard protocol M07-A9 from the 
Clinical and Laboratory Standards Institute, with some modifications50. For the assay, the standard inoculum was 
prepared in sterile saline (0.85% w/v) from living colonies of the selected bacteria above contained in plates of 
TSA agar (E. coli) or MRS agar (Lactobacillus spp.) at the optical density equivalent to 0.5 McFarland Standard 
(0.08–0.13 at 625 nm) as described previously. Subsequently, this inoculum was diluted at 1:100 to obtain an inoc-
ulum of 106CFU/mL (final inoculum). The EO stock solution was prepared at 29.6 mg/mL (3.29%) with MH or 
MRS broth using Tween 80 as emulsifier. From the stock solution, two-fold serial dilutions were made in a range 
from 14.80 to 0.116 mg/mL along the Y-axis of the microplate. Twenty microliters from the final inoculum were 
added to each well containing 180 µL of several EO concentrations, being the final volume in each well of 200 µL 
and bacterial population of approximately 105 CFU/mL. The following controls were used: culture medium con-
trol (200 µL of MH or MRS broth); growth control (180 µL of MH or MRS broth +20 µL of inoculum); Tween 
80-emulsifier control (200 µL of MH or MRS broth with Tween 80) and growth control containing the emulsi-
fier (180 µL of MH or MRS broth with Tween 80 + 20 µL of inoculum). Finally, microplates were incubated in a 
microplate reader (VitorTM X3, PerkinElmer) at 37 °C for 24 h for E. coli and at 30 °C for 36 h for Lactobacillus spp.
The MIC was established as the lowest EO concentration that inhibited visible bacterial growth. The existence 
or not of bacterial growth was evaluated by construction of survival curves and by resazurin test at the end of 
the incubation period. The lowest concentration that did not produce detectable absorbance values (at 600 nm) 
until the end of incubation was considered as the MIC obtained by survival curves. For resazurin test, 25 µL of 
resazurin (R7017; Sigma-Aldrich) solution at 0.0135% m/v were used per well. Thus, after visual inspection the 
presence of viable cells was evidenced through a change in the resazurin color from blue resazurin to pink reso-
furin51, after further incubation at 37 °C (E. coli) or 30 °C (Lactobacillus spp.) for 1 h. Assays were carried out in 
triplicate in three independent replicates.
Bacterial growth modeling and calculation of kinetics parameters. Bacterial growth kinetics (or survival curves) 
for each tested EO concentration was built from absorbance readings at 600 nm of the wells of the microplate 
configured as above, carried out every hour during the total incubation period, 24 h for E. coli and 36 h for 
Lactobacillus spp. Bacterial growth kinetics were modeled using the Gompertz model modified by Zwietering 
et al.24 (Eq. (6)), since this model considers the three main biological parameters of bacterial growth. The data 
were fitted to the mathematical model with a confidence level of 95% using the Levenberg–Marquardt algorithm 







texp ( exp ( ( ) 1)) (6)
max
where: y represents the relative population size against time, the A, µmax and λ are the three parameters that 
described three phases of the bacterial growth curve24. The asymptote A is the maximal bacterial culture density 
(OD600 nm), µmax represents the maximum specific growth rate (h−1) and it is the tangent of the log phase curve, 
λ is the lag phase duration (h) and is defined as the x-axis intercept of this tangent. e represents the number e = 
2.7183.
Finally, the goodness of fit for the model was measured based on the mean square error (MSE) and on the 
corrected determination coefficient (corrected R2) for each set of data.
Minimal bactericidal concentration (MBC). The determination of MBC was performed from wells containing 
EO concentrations where there was no visible bacterial growth. So, an aliquot of 100 µL was taken from each well 
and seeded in MH or MRS agar. Plates were incubated for 24 h at 37 °C for E. coli and for 48 h for Lactobacillus 
spp. The MBC was defined as the lowest concentration of EO able to cause total bacterial death, represented by 
the visible absence of colonies on the agar plates.
chemical composition of essential oils. The chemical composition characterization of the EOs was per-
formed by gas chromatography coupled with mass spectrometry (GC/MS) using non-polar and polar columns.
The analysis on non-polar column was carried out using an Agilent Technology gas chromatograph 6890 Plus 
Series (Santa Clara, CA, USA) coupled to a selective Mass Spectrometry Detector 5973 and an Auto Sampler 7893. 
A fused-silica capillary column DB-5MS (J&W Scientific, Folsom, CA, USA) of 60 m × 0.25 mm id × 0.25 μm of 
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film thickness coated with 5%-phenyl polydimethylsiloxane was used. The oven temperature was set as follows: 
initial oven temperature was held at 45 °C for 5 min, then raised to 150 °C at 4 °C/min for 2 min, one more time 
raised to 250 °C at 5 °C/min, and finally to 300 °C at 10 °C/min, which was kept for 60 min. The injector temper-
ature was 250 °C, 2.0 µL of samples diluted in dichloromethane was injected in the “split” mode at a ratio of 30:1. 
EIMS, electron energy was 70 eV. The mass detector operated in full scan mode in the range of 40 to 350 m/z. 
The temperature of the ion source and transfer line was 230 °C and 285 °C, respectively. Helium gas was used as 
the carrier gas with an inlet pressure of 16.97 psi. The retention index (RI) was calculated for all the volatile com-
pounds using a homologous series of C7–C30 n-alkanes (49451-U Sigma-Aldrich), according the linear equation 
of Van den Dool and Kratz52.
The analysis on polar column was carried out using an Agilent Technology gas chromatograph 7890a Plus 
Series (Palo Alto, CA, USA) coupled to a selective Mass Spectrometry Detector 5975 C. A fused-silica capillary 
column DB-WAX (J&W Scientific, Folsom, CA, USA) of 60 m × 0.25 mm i.d × 0.25 μm of film thickness coated 
with polyethylene glycol was used. The oven temperature was set as follows: initial oven temperature was held at 
50 °C for 5 min, then raised to 150 °C at 4 °C/min for 7 min and finally to 230 °C at 4 °C/min, which was kept for 
40 min. The injector temperature was 250 °C, 2.0 µL of samples diluted in dichloromethane was injected in the 
“split” mode at a ratio of 30:1. EIMS, electron energy was 70 eV. Helium gas was used as the carrier gas with an 
inlet pressure of 16.91 psi. Mass detector operated in full scan mode in the range of 40 to 350 m/z. The retention 
index (RI) was calculated for all the volatile compounds as described above.
The identification of the components was performed by comparing their RI and mass spectra with data pub-
lished in the literature53,54 and in the computer libraries (NIST 107 and WILEY 8).
Data analysis. The IZD data from the initial screening was evaluated by analysis of variance (ANOVA) fol-
lowed by the Tukey test for pairwise comparison at 5% of significance using XLSTAT (Addinsoft, New York, NY, 
USA). Based on this, the susceptibility of ETECs strains and Lactobacillus species was determined. Also, principal 
component analysis (PCA) using the correlation matrix was performed based on IZDs means using XLSTAT 
(Addinsoft, New York, NY, USA).
Furthermore, an ANOVA to detect significant differences in the growth kinetics parameters A, λ and µmax of 
E. coli and Lactobacillus spp. after exposure to EO concentrations was performed (p < 0.05) using R software. If 
significant differences were detected in those parameters, as effect of the EO concentrations, the behavior of each 
parameter was modeling by nonlinear regression.
In addition, the multiple factor analysis (MFA) was performed on polar and non-polar data (two tables) to 
describe and contrast the chemical composition profile of the six citrus EOs obtained by GC-MS, with this anal-
ysis running in the XLSTAT software.
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